HopeStage
Back to all studies
RecruitingNCT06112067

Combined deep brain stimulation studied across several mental health conditions, including bipolarity

About this titleRead the official source — NCT06112067
Device studyAges 18–65ChinaOCD
The study in practice

Understand this study

Who could participate?

Listed age limits: 18 years to 65 years.

Listed locations
ShanghaiSee all locations and recruitment

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateStarted: October 16, 2023
Recruitment status
Recruiting
Enrollment listed in the registry
18
Sponsor
Shanghai Mental Health Center
Sponsor type
Hospital / academic medical center
Study type
Device
Intervention type
Device
Locations
China
Age range
From 18 Years to 65 Years
Official registry ID
NCT06112067
Official title
Show the full official title

Efficacy and Safety of Combo-stim Deep Brain Stimulation for Treatment-refractory Mental Disorders: a Multi-center, Single Arm, Prospective, Open-label, Extendable Study

Recruitment & locations

Currently recruiting

Shanghai

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Shanghai Mental Health Center, a hospital or academic medical center.

Who can participate?

Listed age limits: 18 years to 65 years.

Is this study still recruiting?

The registry lists this study as recruiting.

Want to explore more studies?

Explore studies